Impact of Concomitant Therapy with a Dopamine Agonist on Converting Parkinson’s Disease Patients from Immediate-release Carbidopa-levodopa to CREXONT® (P7-5.024)
To assess the effect of concomitant Parkinson’s disease (PD) medication use on the efficacy of CREXONT (IPX203).
Authors
- Rajesh Pahwa (ORCID: https://orcid.org/0000-0003-3176-6466)
- Ramsey Falconer
- Neepa Patel (ORCID: https://orcid.org/0000-0002-0073-9783)
- Stanley E. Fisher
- Simon Allard
- Ghazal Banisadr
Institutions
- Rush University Medical Center (US)
- Amneal (India) (IN)
- Centre for Movement Disorders (CA)
- University of Kansas Medical Center (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211199
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00